Pakistan’s first Vitamin D3 200000IU with Magnesium Glycinate and K2

MAGROL

Pakistan’s First Triple-Combination Softgel

Vitamin D3 200,000 IU  |  Magnesium Glycinate 500 mg  |  K2 MK-7 210 mcg

DRAP Registered  |  Hikanzu Pharma

Product Description

Magrol is Pakistan’s first DRAP-registered Softgel combining a high-dose Vitamin D3 200,000 IU loading dose with the superior bioavailability \

of Magnesium Glycinate and the arterial-protective power of Vitamin K2 as MK-7  in a single, precision-formulated capsule.

Most patients prescribed high-dose D3 receive it in isolation. But science tells a different story: Vitamin D3 cannot perform optimally without magnesium to activate it, and cannot direct calcium safely without K2 to guide it. Magrol closes this gap — delivering all three co-factors together, exactly as the body needs them.

Why This Combination Matters

Vitamin D3  200,000 IU

A clinically validated loading dose for rapid correction of Vitamin D deficiency, one of the most prevalent nutritional deficiencies in Pakistan. Stored in adipose tissue and released gradually for sustained therapeutic effect.

Magnesium Glycinate  500mg

Magnesium is the essential cofactor for converting inactive D3 into its active hormonal form (1,25-dihydroxyvitamin D). Without adequate magnesium, supplemental D3 remains biologically inert. The glycinate form ensures superior absorption with minimal gastrointestinal discomfort.

Vitamin K2 MK-7 210mcg

The long-chain MK-7 form of K2 activates osteocalcin and Matrix Gla Protein (MGP), directing calcium into bones and away from arteries. High-dose D3 increases calcium absorption K2 ensures that calcium goes where it belongs.

Clinical Significance

• Corrects D3 deficiency faster and more completely by addressing magnesium-dependent activation
• Supports bone mineralisation through the D3–K2–calcium axis
• Protects vascular health by preventing soft tissue calcium deposition
• Reduces the risk of D3-induced hypercalcaemia through K2-mediated calcium regulation
• Addresses the widely under-recognised magnesium depletion seen in D-deficient patients

The Magrol Difference

Indicated For

• Vitamin D deficiency and insufficiency
• Osteoporosis and osteopenia
• Musculoskeletal pain and weakness
• Immune dysfunction
• Metabolic syndrome
• Post-menopausal bone loss
• Patients on corticosteroids or anticonvulsants